Importantly, we demonstrated that the S100A8 inhibitor, paquinimod, diminished S100A8+ immune cells in BAT, therefore ameliorating obesity-associated metabolic dysfunction in aged mice. This evidence concerns the gene S100A8 and obesity due to melanocortin 4 receptor deficiency.